RADIOIMMUNOGUIDED SURGERY IN GASTRIC-CANCER USING 131-I LABELED MONOCLONAL-ANTIBODY 3H11

被引:16
作者
XU, GW
ZHANG, MY
LIU, BG
LI, ZF
LIN, BH
XU, XB
JIN, ML
LI, JY
WU, J
DONG, ZW
机构
[1] Department of Surgery, Beijing Institute for Cancer Research, Beijing
[2] Department of Nuclear Medicine, Beijing Institute for Cancer Research, Beijing
[3] Department of Biochemistry and Molecular Biology, Beijing Institute for Cancer Research, Beijing
[4] Department of Gastrointestinal Disease, Beijing Institute for Cancer Research, Beijing
[5] Department of Pathology, Beijing Institute for Cancer Research, Beijing
来源
SEMINARS IN SURGICAL ONCOLOGY | 1994年 / 10卷 / 02期
关键词
RADIOIMMUNOGUIDED SURGERY; MONOCLONAL ANTIBODY; I-131;
D O I
10.1002/ssu.2980100205
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A clinical trial of radioimmunoguided surgery (RIGS) using 131-I labeled monoclonal antibody (MAb) 3H11 was performed on 25 cases with gastric cancer in this study. The results showed that the route of the administration of radiolabeled MAb is the key point of successful RIGS for gastric cancer. The RIGS in 19 cases in the group of submucosal injection via endoscope was very satisfying. For the detection of metastatic lymph nodes, the sensitivity rate of RIGS was 99.2% (118/119), the specificity, 97.7% (43/44), and the accuracy 98.8% (161/163). The accuracy rate in detecting tumor infiltration of the gastric wall was 95.9% (94/98), the sensitivity 94.6% (35/37), and the specificity 96.7% (59/61). Thus, the use of RIGS may improve the radical resectability rate and possibly the overall survival rate in patients with gastric cancer. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 17 条
[1]  
Mitchell EP, Schlom J, Monoclonal antibodies in gastrointestinal cancers, Semin Oncol, 15, pp. 170-180, (1986)
[2]  
Goldenberg DM, Goldenberg H, Sharkey RM, Et al., Imaging of colorectal carcinoma with radiolabeled antibodies, Semin Nucl Med, 19, pp. 262-281, (1989)
[3]  
Aitken DR, Hinkle GH, Thurston MO, Et al., A gamma‐detecting probe for radioimmune detection of CEA producing tumors: Successful experimental use and clinical case report, Dis Colon Rectum, 27, pp. 279-282, (1984)
[4]  
Martin DT, Hinkle GH, Tuttle S, Et al., Intraoperative radioimmunodetection of colorectal tumor with a hand‐held radiation detector, Am J Surg, 150, pp. 672-675, (1985)
[5]  
O'Dwyer PJ, Mojzisik GM, Hinkle GH, Et al., Intraoperative probe‐directed immunodetection using a monoclonal antibody, Arch Surg, 121, pp. 1391-1394, (1986)
[6]  
Moldofsky PJ, Sears HF, Mulhern CB, Et al., Detection of metastatic tumor in normal‐sized retroperitoneal lymph nodes by monoclonal‐antibody imaging, N Engl J Med, 311, pp. 106-107, (1984)
[7]  
Wei S, Liu X, Li J, Et al., Monoclonal antibodies against gastric cancer and their selective reaction on various tissues, Chin J Cancer, 11, pp. 162-164, (1989)
[8]  
Zhang M, Dong Z, Xu X, Et al., Investigation of in vivo distribution of labelled monoclonal antibody 3G9 and its F(ab')<sub>2</sub> fragment and 3H11 in tumor bearing nude mice, Chin J Nucl Med, 9, pp. 154-157, (1989)
[9]  
Ji J, Zhang M, Dong Z, Et al., Clinical study of radioimmunoimaging with anti‐human gastric cancer monoclonal antibodies, Chin J Nucl Med, 12, pp. 88-90, (1992)
[10]  
Fraker PJ, Protein and cell membrane iodinations with a sparingly soluble chloromide 1,3,4,6‐tetrachloro‐3α,6α diphenylglycoluril, Biochem Biophys Res Commun, 80, pp. 849-857, (1978)